Geron: Late-stage biopharmaceutical company pursuing therapies with the potential to extend and enrich the lives of patients living with hematologic malignancies. First-in-class telomerase inhibitor, imetelstat, harnesses Nobel Prize-winning science in a treatment that may alter the underlying drivers of disease. Two Phase 3 pivotal clinical trials underway evaluating imetelstat in lower risk myelodysplastic syndromes (LR MDS), and in relapsed/refractory myelofibrosis (MF), with initial top-line data in LR MDS expected early Jan 2023).
Based in...
US - Pacific
Clinical Stage
Phase l or ll
Disease Space
Hematology, Oncology
Public, USA
Market Cap
1B +
Therapeutic Modalities
Small Molecule
Menlo Park, CA
United States

Company Participants at Solebury 1x1 Management Access Event 2023

  • Edward Koval, CBO
  • John Scarlett, M.D., President & CEO

Top 10 Holders of Geron Corporation

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
RA Capital Management LP 6.20 31,544,806 66.87 13F 6/30/23
Vanguard Group, Inc. (Subfiler) 5.01 25,509,083 54.08 13F 6/30/23
Deep Track Capital LP 4.75 24,170,966 51.24 13F 6/30/23
TCG Crossover Management LLC 4.64 23,589,779 50.01 13F 6/30/23
NEA Management Co. 4.20 21,347,838 45.26 13F 6/30/23
State Street Corp. 4.18 21,278,062 45.11 13F 6/30/23
BlackRock Fund Advisors 3.89 19,810,781 42.00 13F 6/30/23
Vivo Capital LLC 3.25 16,524,634 35.03 13F 6/30/23
BlackRock Institutional Trust Co. NA 2.42 12,328,382 26.14 13F 6/30/23
Millennium Management LLC 2.40 12,208,289 25.88 13F 6/30/23
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.